TNF and cancer: However, those findings have been contradicted by evidence from recent studies: Use of anti-tumor necrosis factor therapy after an initial cancer diagnosis does not influence recurrence or new cancer (Waljee et al., 2020), and patients with inflammatory bowel disease who are treated with this therapy have lower rates of colorectal cancer (Alkhayyat et al., 2020).